IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time.
Hoeh B, Flammia RS, Hohenhorst L, Sorce G, Panunzio A, Tappero S, Tian Z, Saad F, Gallucci M, Briganti A, Terrone C, Shariat SF, Graefen M, Tilki D, Antonelli A, Kosiba M, Kluth LA, Becker A, Chun FKH, Karakiewicz PI.
Hoeh B, et al. Among authors: kosiba m.
Semin Oncol. 2022 Oct;49(5):394-399. doi: 10.1053/j.seminoncol.2022.10.001. Epub 2022 Oct 23.
Semin Oncol. 2022.
PMID: 36333148
Review.